Literature DB >> 21735293

Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

Bettina Schrag1, Pascale Roux-Lombard, Deborah Schneiter, Paul Vaucher, Patrice Mangin, Cristian Palmiere.   

Abstract

The aims of this study were to investigate the usefulness of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as postmortem markers of sepsis and to compare C-reactive protein and procalcitonin values in serum, vitreous humor, and cerebrospinal fluid in a series of sepsis cases and control subjects, in order to determine whether these measurements may be employed for the postmortem diagnosis of sepsis. Two study groups were formed, a sepsis group (eight subjects coming from the intensive care unit of two university hospitals, with a clinical diagnosis of sepsis in vivo) and control group (ten autopsy cases admitted to two university medicolegal centers, deceased from natural and unnatural causes, without elements to presume an underlying sepsis as the cause of death). Serum C-reactive protein and procalcitonin concentrations were significantly different between sepsis cases and control cases, whereas serum tumor necrosis factor alpha, interleukin-6, and interleukin-8 values were not significantly different between the two groups, suggesting that measurement of interleukin-6, interleukin-8, and tumor necrosis factor alpha is non-optimal for postmortem discrimination of cases with sepsis. In the sepsis group, vitreous procalcitonin was detectable in seven out of eight cases. In the control group, vitreous procalcitonin was clearly detectable only in one case, which also showed an increase of all markers in serum and for which the cause of death was myocardial infarction associated with multi-organic failure. According to the results of this study, the determination of vitreous procalcitonin may be an alternative to the serum procalcitonin for the postmortem diagnosis of sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735293     DOI: 10.1007/s00414-011-0596-z

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  17 in total

1.  Post-mortem markers of sepsis: an immunohistochemical study using VLA-4 (CD49d/CD29) and ICAM-1 (CD54) for the detection of sepsis-induced lung injury.

Authors:  M Tsokos; F Fehlauer
Journal:  Int J Legal Med       Date:  2001       Impact factor: 2.686

2.  The routine use of C-reactive protein in forensic investigations.

Authors:  B S Astrup; J L Thomsen
Journal:  Forensic Sci Int       Date:  2007-01-12       Impact factor: 2.395

3.  Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.

Authors:  Y Heper; E H Akalin; R Mistik; S Akgöz; O Töre; G Göral; B Oral; F Budak; S Helvaci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

4.  Serum C-reactive protein levels in postmortem blood--an analysis with special reference to the cause of death and survival time.

Authors:  Masaki Q Fujita; Bao-Li Zhu; Kaori Ishida; Li Quan; Shigeki Oritani; Hitoshi Maeda
Journal:  Forensic Sci Int       Date:  2002-12-04       Impact factor: 2.395

5.  Immunohistochemical expression of E-selectin in sepsis-induced lung injury.

Authors:  M Tsokos; F Fehlauer; K Püschel
Journal:  Int J Legal Med       Date:  2000       Impact factor: 2.686

6.  C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels.

Authors:  L Uhlin-Hansen
Journal:  Forensic Sci Int       Date:  2001-12-15       Impact factor: 2.395

7.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

8.  Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia.

Authors:  Hitoshi Maeda; Bao-Li Zhu; Yasumori Bessho; Takaki Ishikawa; Li Quan; Tomomi Michiue; Dong Zhao; Dong-Ri Li; Ayumi Komatsu
Journal:  Forensic Sci Med Pathol       Date:  2008-02-07       Impact factor: 2.007

9.  Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein.

Authors:  Takaki Ishikawa; Marianne Hamel; Bao-Li Zhu; Dong-Ri Li; Dong Zhao; Tomomi Michiue; Hitoshi Maeda
Journal:  Forensic Sci Int       Date:  2008-06-09       Impact factor: 2.395

10.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

View more
  16 in total

1.  Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis.

Authors:  Bettina Schrag; Katia Iglesias; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-03-29       Impact factor: 2.686

Review 2.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

3.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

4.  Postmortem angiography using femoral cannulation and postmortem microbiology.

Authors:  Cristian Palmiere; Coraline Egger; Silke Grabherr; Katia Jaton-Ogay; Gilbert Greub
Journal:  Int J Legal Med       Date:  2014-11-08       Impact factor: 2.686

5.  Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities.

Authors:  Cristian Palmiere; Michele Mussap; Daniel Bardy; Francesco Cibecchini; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-12-22       Impact factor: 2.686

6.  Procalcitonin as a postmortem sepsis marker. A comparison of the validity of results obtained from blood serum, aqueous humour and cerebrospinal fluid.

Authors:  S Schmidt; M Windgassen; J-R Nofer; H Pfeiffer; S Ribbecke; A Schmeling
Journal:  Int J Legal Med       Date:  2014-08-14       Impact factor: 2.686

7.  A systems biological approach reveals multiple crosstalk mechanism between gram-positive and negative bacterial infections: an insight into core mechanism and unique molecular signatures.

Authors:  R Muthukumar; V Alexandar; Berla Thangam; Shiek S S J Ahmed
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  A diabetic ketoacidosis in a context of hyperglycemia addiction.

Authors:  Guillaume Rousseau; Cristian Palmiere; Vincent Dupont; Marion Verschoore; Caroline Savary; Nathalie Jousset; Clotilde Rougé-Maillart
Journal:  Int J Legal Med       Date:  2017-10-15       Impact factor: 2.686

9.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

10.  Detection of Serum Interleukin-6/10/18 Levels in Sepsis and Its Clinical Significance.

Authors:  Mingchen Feng; Tingting Sun; Yaxin Zhao; Hui Zhang
Journal:  J Clin Lab Anal       Date:  2016-05-17       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.